The use of exogenous NGF has been proven to complement the pathological absence of NGF and play the role in promoting the repair of nerve damage in vitro, making NGF a promising therapeutic agent for neural repair in the treatment of CNS diseases such as Alzheimer's disease (SCI) [18]. The gene discussed is NGF; the disease is early-onset autosomal dominant Alzheimer disease.